Trisha Larkin

Missed the Clinical Vendor Evaluation Webinar? No Worries! Rob Aitchison, Anca Copaescu, Kara Titus, Brenda medina, Scott Sawicki recently spoke in an insightful webinar for Strategikon on Mastering Clinical Vendor Evaluation for Superior Trial Outcomes. If you couldn't join us live, you're still in luck! The recording and presentation slides are now available here: https://lnkd.in/eNEUmK3g In this session, you'll learn about: ✅ The importance of category management in vendor selection. ✅ Key criteria for effective vendor onboarding processes. ✅ How to set and measure vendor evaluation workflows. ✅ Risk management strategies for vendor qualification. ✅ Latest trends and innovations in clinical vendor management. Don't miss out on this valuable resource! If you’d like to learn more about how you can master your clinical vendor evaluation, reach out to Rob Aitchison or Will Sillar. #clinicaltrials #vendormanagement #webinar #strategikon

9

2 Comments

CDAS Tech Enabled Services grants sponsors access to real time clinical data and operational data from IQVIA or outsourced studies from other clinical research organizations (CROs) with ease. Request a demo: https://bit.ly/3Lr9Hob #ClinicalResearch #ClinicalData

18

Pharma sponsors are increasing their trust in AI-powered digital biomarkers and sensor-based COAs to capture primary and secondary endpoints. Read the data in our blog: https://ow.ly/80uJ50SSQz8 #ClinicalTrials #DigitalHealth #AI"

41

1 Comment

The new Order Tracker Experience (OTE) gives providers real-time visibility of test order status. Whether you order through your EHR, Labcorp Link or manual requisition, OTE offers comprehensive tracking, enhancing your ability to manage patient care effectively with clear, up-to-date information on all your test orders. Learn how OTE can enhance your test ordering experience: https://lnkd.in/ejejbXSk #OrderTrackingExperience #EHR

9

To improve #medicationadherence, retail pharmacists must adopt a digital strategy to engage patients—or risk being left behind. Learn more in our Expert Insight by Christian Hartman, PharmD, MBA, FSMSO. https://ow.ly/5k5o50TTBR2 #PharmacyInnovation #RetailPharmacy #DigitalHealth

1

Humana's William Fleming, PharmD talks about one of the values of #PBMs - which is the sharing of information to enable #doctors and #patients to make better health care decisions. It's #HowPBMsWork. Learn more at http://HowPBMsWork.org

16

9 Comments

The TriNetX network empowers investigators to focus on solving their clinical questions instead of data wrangling. Learn how you can save time on your projects here: https://ow.ly/CsYM50Sjeun #RealWorldData #HealthcareInnovation #ClinicalTrials

27

MAIA reporting automates and simplifies mandatory #lifesciencesreporting functions - including CSR, DSUR, TLF, and more – using a powerful combination of #genAI and human-in-the-loop presence. It’s past time to reclaim lost time and focus on what matters most: serving patients. Visit https://lnkd.in/eAXbX6hG #lifesciencesAI #lifesciences compliance #healthcarecompliance

13

If you build it, will they come? Paying for Cures can help you predict market numbers. Beyond payer coverage decisions, patient and provider considerations influence the decision to use a #CGT. Get insights on the factors that challenge adoption: Ask PAM: How soon? Access a listing of disease characteristics and treatment options and see the NEWDIGS assessment of their impact on adoption. https://lnkd.in/ewbBfTy5 Gain insights on market adoption issues faced by payers, developers, and patients. https://lnkd.in/ewuHxWSr Understand the challenges faced by patients and caregivers who must navigate the health system to gain treatment access. https://lnkd.in/eMihrPpZ #celltherapy #genetherapy

3

In today's Expert Contributor, Sandra Sanchez-Oldenhage, President & CEO of PharmaAdvice/BizAdvice, explains how the sanctity of patient data, once safely secured in medical offices, now faces an onslaught of digital predators. #MexicoBusinessNews #MexicoBusiness #ExpertOpinion

2

READ: This poster, based on research by McKesson Director of Payer Analytics John Albaugh, delivered at this year's American Society of Clinical Oncology (ASCO) Annual Meeting, discusses how biosimilars can help bring down healthcare costs and make treatment more accessible to more patients. Read the full article below. https://lnkd.in/eFbhn2vP #HealthInnovation #HealthcareCosts #ASCO2024

32

1 Comment

In the evolving landscape of #ClinicalResearch, #HomeTrials are gaining prominence because of their patient-friendly approach. Read our blog to learn how partnering with a specialty #CRO can improve your study. https://bit.ly/3w8tncw

8

READ NOW: NAVLIN Last Week in Review https://ow.ly/BS0R50SRgSX This week from NAVLIN by EVERSANA's “Last Week in Review,” recapping the latest regulatory changes, pricing & reimbursement updates, drug approvals and more from across the world: Policy: As the U.S. BIOSECURE Act advances, biotech partnerships between the U.S. and China face new challenges. Discover how WuXi AppTec’s U.S. revenues are impacted. #BiotechPolicy Pricing & Reimbursement: China’s basic medical insurance system saw significant improvements in 2023. Learn about the widened trans-provincial billing and reduced medical expenses through bulk purchasing. #HealthcareReform HTA: NICE’s final appraisal guidance on AstraZeneca’s/Daiichi Sankyo’s Enhertu for advanced HER2-low breast cancer reveals cost-effectiveness concerns. Find out why it wasn’t recommended for NHS use. #HealthTechnologyAssessment Drug Approval: The UK MHRA’s 2023/2024 Annual Report highlights key drug approvals, including Mounjaro for weight loss and Casgevy for sickle cell disease. Explore the full list of notable approvals. #DrugApproval Regulation: The Egyptian Drug Authority’s new regulatory guide for biological product registration is here. Get the details on EDA’s Chairman’s Decree No. 343 of 2021. #PharmaRegulation Other: The OTC pharmaceuticals market in Saudi Arabia is set to grow, reaching USD 239.90 million by 2024. Discover the factors driving this steady increase. #OTCMarket And more...

6

Discover ways to bridge gaps between study teams and tech providers for better outcomes in a recent ACRP blog > https://bit.ly/4df7Z58 Chris Bryant of Array highlights the need for the pharmaceutical industry to optimize metrics and utilize technology to convert data from investigator meetings into meaningful strategies. The full article will be available in the upcoming August 2024 issue of ACRP's Clinical Researcher Journal. #ClinicalResearch #ClinicalTrials #ClinicalResearcher #Pharma

7

Check out this article in ACRP - Association of Clinical Research Professionals where our very own Chris B. highlights the importance of converting raw data from investigator meetings into actionable insights. With the right technology partner, turning data into impactful metrics is seamless, bridging gaps between study teams and stakeholders. Read the rest of the article to discover how to make your data work for you!

8

The news coming live from Trust ’24 Philadelphia doesn’t stop! We’re excited to introduce the Data Graph API, a new addition to the Data Enrichment service within the Precisely Data Integrity Suite! For the first time, a single API offers simplified access to the Precisely data portfolio for flexible queries, data enrichment, and enhanced data discovery. Learn more here: https://okt.to/2gCkxc #DataEnrichment #DataIntegrity #Trust24

42

Pharma companies are approaching market access planning early, using real-world data and AI. https://ow.ly/WlRc50SEHW1 In Life Science Leader, MMIT and The Dedham Group experts explain why increased financial pressures have resulted in greater investment in market access. #MarketAccess #Pharma #PharmaCompanies

6

Learn how the Cloudbyz Vet eClinical Platform aligns with the latest FDA guidelines https://hubs.li/Q02ynCmR0

1